170443 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Hormones
Sub-classes:BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF
#2SEMI-QUANTITATIVE LATERAL FLOW DEVICE AND METHOD FOR DETECTING BIOMARKERS IN UNPROCESSED SALIVA
#3PCOS STRATIFICATION
#4CIS-TRANS ISOMERIZATION OF OXYTOCIN
#5DEVICE, METHOD AND SYSTEM FOR DIAGNOSING, MONITORING AND PREDICTING CHRONIC HEALTH CONDITIONS THROUGH URINE BIOMARKERS
#6Method for the prediction of a risk or severity of side effects in a cancer patient that is to be treated or has been treated with immune effector cell therapy (IECT)
#7Pro-ADM for Prognosis of Trauma-Related Complications in Polytrauma
#8METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#9BIOMARKER FOR DIAGNOSING CENTRAL PRECOCIOUS PUBERTY IN FEMALES AND USES THEREOF
#10MMP-14 OR TIMP POTENCY ASSAY FOR MESENCHYMAL STEM CELLS
#11REAGENT COMBINATION, KIT, DETECTION SYSTEM AND DETECTION METHOD FOR DETECTING SMALL MOLECULE SUBSTANCE
#12ENHANCED SMALL MOLECULE DETECTION AND QUANTITATIVE ANALYSIS
#13METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#14Birth Control Efficacy Monitoring Device
#15MICROENVIRONMENTAL DETERMINANTS OF CLONAL HEMATOPOIESIS EXPANSION RATE
#16SYSTEM FOR EVALUATING OVARIAN RESERVE FUNCTION OF SUBJECT
#17HIGH SENSITIVITY AND SELECTIVITY VERTICALLY-ORIENTED SILICON NANOWIRE ARRAY-BASED BIOELECTRONIC SENSOR PLATFORM
#18METHOD FOR QUANTIFYING ACTIVE OREXIN A
#19SAMPLE INCLUDING PRO-ADM AS A THERAPY MONITORING MARKER FOR CRITCALLY ILL PATIENTS
#20COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CARDIOMYOPATHY IN A FELINE
#21ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING SUICIDAL BEHAVIORS IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#22METHODS OF DETECTING ANTI-LEPTIN NEUTRALIZING ANTIBODIES
#23De Novo Designed Cortisol Biosensor
#24SHBG AND IBP4 ANTIBODIES AND METHODS USING SAME
#25HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF
#26SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT
#27NOVEL BIOMARKER FOR DIAGNOSING AND PREDICTING METASTASIS OR PROGNOSIS OF VARIOUS CANCERS, AND USE
#28BIOMARKERS AND METHODS FOR ASSESSING MYOCARDIAL INFARCTION AND SERIOUS INFECTION RISK IN RHEUMATOID ARTHRITIS PATIENTS
#29DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER
#30A Biomarker for Breast Cancer Diagnosis Using Estrogen in Exosomes and a Breast Cancer Diagnosis Kit Using the Biomarker
#31COMPOSITIONS AND METHODS FOR PREVENTING OR DELAYING PUBERTY IN PREPUBESCENT NON-HUMAN ANIMALS AND HUMANS
#32UNIVERSAL CALIBRATION FOR QUANTITATIVE MASS SPECTROMETRY
#33BIOMARKER COMBINATIONS TO SIMULTANEOUSLY EVALUATE NON-ALCOHOLIC STEATOHEPATITIS AND HEPATIC FIBROSIS STATUS
#34METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS
#35Biosensor Based Tool to Monitor Obesity
#36METHODS AND SYSTEMS FOR DETECTION AND ANALYSIS OF ANGIOTENSIN BINDING ANTIBODIES
#37BIOMARKER, FOR DIAGNOSING PANCREATIC CANCER, COMPRISING ASPROSIN, AND USE THEREOF
#38INTERFERENCE MONITORING FOR PROVIDING A VERIFIED ANALYTE MEASUREMENT
#39METHODS OF DETECTING ANTI-LEPTIN NEUTRALIZING ANTIBODIES
#40METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
#41COMPOSITIONS AND METHODS FOR TREATING PULMONARY EDEMA OR LUNG INFLAMMATION
#42ANTI-PACAP ANTIBODIES AND USES THEREOF
#43METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AN ALLERGY OR ANAPHYLAXIS
#44HEART FAILURE MARKER
#45PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY
#46BIOMARKERS FOR JOINT AILMENTS AND USES THEREOF
#47THERAPY MONITORING UNDER TREATMENT WITH AN ANTI-ADRENOMEDULLIN (ADM) BINDER
#48Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
#49Pro-ADM for Prognosis of Trauma-Related Complications in Polytrauma Patients
#50Method for evaluating urine of a subject to estimate the fertile window by evaluating for the presence of analytes of estrogen and progesterone
#51System and method for diagnosis and treatment
#52Production and Enrichment of Pancreatic Endocrine Progenitor Cells
#53Method for evaluating urine of a subject to estimate the fertile window
#54BIOMARKER FOR DIAGNOSING AUTISM SPECTRUM DISORDER
#55Metal-organic frameworks for electrochemical detection of analytes
#56Intranasal vasopressin treatment of social deficits in autism
#57Methods and Systems for Measuring Plasma Renin Activity
#58METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
#59METHODS OF SUPPORTING WEIGHT MAINTENANCE BY DECREASING THE ACTIVITY OF FAM46A
#60Systems and methods for sample use maximization
#61Biosensor for Diagnosis of Thyroid Dysfunction
#62METHOD FOR EVALUATING COMFORT EVOKING PERFORMANCE OF SHEET AND COMFORT EVOKING SHEET
#63Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients
#64Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
#65BIOMARKERS AND USES THEREOF
#66METHOD FOR MEASURING SYSTEMIC CHRONIC INFLAMMAGING
#67Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
#68Methods for treating and diagnosing metastatic liver cancer
#69System and method for diagnosis and treatment
#70DIGITAL IMMUNOASSAY
#71Methods of detecting anti-leptin neutralizing antibodies
#72Methods and systems for the detection of 11-oxo androgens by LC-MS/MS
#73KITS FOR DETECTION OF HEPCIDIN
#74PRO-ADM AS A THERAPY MONITORING MARKER FOR CRITCALLY ILL PATIENTS
#75Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients
#76Biomarkers for joint ailments and uses thereof
#77METHOD FOR GUIDANCE OF FLUID THERAPY BASED ON PROADRENOMEDULLIN
#78PROADRENOMEDULLIN AS INDICATOR FOR RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS
#79ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE
#80Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status
#81METHODS OF MODULATING FAM46A
#82Humanized anti-PACAP antibodies
#83Humanized anti-PACAP antibodies
#84Humanized anti-PACAP antibodies
#85Diagnosis of diabetes by detecting aggregated amylin in erythrocytes
#86Method of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
#87Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#88Method for diagnosing mood disorder by using circadian rhythm
#89BRAIN OSTEOCALCIN RECEPTOR AND COGNITIVE DISORDERS
#90Antibody Compositions and Immunoassay Methods to Detect Isoforms of Anti-Müllerian Hormone
#91Lipid nanodisc formation by acryloyl-based copolymers
#92USE OF IN1-GHRELIN FOR THE DIAGNOSIS OF PROSTATE CANCER
#93Methods of diagnosing endometriosis
#94Anti-PACAP antibodies and uses thereof
#95Compositions and methods for measuring NMU and for treatment using anti-NMU agents
#96PAC1 antibodies and uses thereof
#97Method for preparing anti-AMH antibodies and uses of same
#98Diagnosis and anti-Mullerian hormone (AMH) administration for treatment of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models
#99System and method for diagnosis and treatment
#100ASPROSIN, A FAST-INDUCED GLUCOGENIC PROTEIN HORMONE
#101Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#102System and method for real-time insurance quote in response to a self-diagnostic test
#103Kit and method for measuring prostaglandin E-major urinary metabolite
#104PROGNOSIS OF SEROUS OVARIAN CANCER USING BIOMARKERS
#105Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome
#106DETERMINING ONSET OF A SLEEP-RELATED ANALYTE
#107Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
#108System and method for diagnosis and treatment
#109MARKERS FOR CORONARY ARTERY DISEASE AND USES THEREOF
#110MR-proADM as marker for the extracellular volume status of a subject
#111Stress biomarkers and related non-invasive detection methods
#112Monomeric and Dimeric Forms of Adiponectin Receptor Fragments and Methods of Use
#113System and Method for Diagnosis and Treatment
#114ADHD MARKER, APPLICATION THEREOF AND KIT
#115Polypeptides, nucleic acids and uses thereof
#116Digital immunoassay
#117COMPOUNDS AND METHODS FOR PREPARATION OF CONJUGATE REAGENTS
#118Testosterone Saliva Test
#119Methods and systems for measuring plasma renin activity
#120Methods for Inhibiting the Development of Huntington's Disease
#121Methods of detecting anti-leptin neutralizing antibodies
#122Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome
#123Lateral Flow Analyte Detection
#124Systems and methods for sample use maximization
#125Anti-PACAP antibodies and uses thereof
#126Humanized anti-PACAP antibodies and uses thereof
#127Methods, agents and compositions for treatment of inflammatory conditions
#128METHOD FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT
#129DIAGNOSTIC METHOD FOR DISORDERS USING COPEPTIN
#130Methods Of Detecting Ectopic Pregnancy
#131Diagnosis, and anti-mullerian hormone (AMH) administration for treatment, of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models
#132Methods for treatment using anti-NMU agents
#133BIOCHEMICAL MARKERS FOR USE IN DETERMINING RISK OF DIABETES
#134Serine derivatives as ghrelin receptor agonists
#135Soluble monomeric anti-Mullerian hormone receptor type II fusion proteins and uses thereof
#136Identification of cancer protein biomarkers using proteomic techniques
#137Diagnostic and prognostic markers for cancer
#138Method for diagnosing sleep apnea by measuring adipsin and betatrophin levels
#139Biomarkers associated with schizophrenia
#140Adrenomedullin to guide therapy of blood pressure decline
#141Measurement of Oxytocin and Vasopressin
#142METHODS, AGENTS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY CONDITIONS
#143QUANTITAQUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
#144Systems and methods for sample use maximization
#145LATERAL FLOW ASSAY APPARATUS AND METHOD, AND SENSOR THERFOR
#146Polypeptides, nucleic acids and uses thereof
#147Methods for Inhibiting the Development of Huntington's Disease
#148System and method for diagnosis and treatment
#149System and method for diagnosis and treatment
#150Antibody Compositions and Immunoassay Methods to Detect Isoforms of Anti-Müllerian Hormone
#151Hepcidin Binding Nucleic Acids
#152Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
#153Compositions and methods for chronic use of a weight-gaining compound
#154METHOD FOR EVALUATING SALIVARY ADIPONECTIN LEVEL AND KIT FOR MEASURING SALIVARY ADIPONECTIN LEVEL
#155Automated Assay
#156METHOD AND SYSTEM FOR SENSING AND DETECTING A TARGET MOLECULE
#157Augurin immunoassay
#158USE OF BUFODIENOLIDES IN DIAGNOSING AND TREATING ESSENTIAL HYPERTENSION
#159GHRELIN IN THE DIAGNOSIS OF CNS DISORDERS
#160Methods for diagnosis and treatment of concussion or brain injury
#161Molecular Template and Manufacturing Method Therefor
#162The cause and possible treatment of thyroid anti-body disease
#163Melatonin monoclonal antibody, detection, methods and uses thereof
#164Systems and methods for sample use maximization
#165Methods and compositions for improving cognitive function
#166Measurement of FGF21 as a biomarker of fructose metabolism
#167METHODS OF DIAGNOSING ENDOMETRIOSIS
#168Treatment of insulin resistance associated with prolonged physical inactivity
#169Identification of cancer protein biomarkers using proteomic techniques
#170Systems and methods for sample use maximization
#171Use of Bufodienolides in Diagnosing and Treating Essential Hypertension
#172SUPPRESSION OF LEPTIN ACTION FOR TREATMENT OF PULMONARY INFECTIONS
#173Rapid analysis of steroids and steroid derivatives
#174IDENTIFICATION OF CANCER PROTEIN BIOMARKERS USING PROTEOMIC TECHNIQUES
#175Modulation of activity of neurotrophins
#176METHODS AND COMPOSITIONS FOR ASSAYING VITAMIN D
#177Systems and methods for sample use maximization
#178METHOD FOR DETECTING OR MONITORING PROSTATE CANCER
#179Method for Predicting the Risk of Getting a Cardiovascular Event in a Female Subject
#180Method and system for detecting and differentiating cancer and sepsis in mammals using biomarkers
#181COMPOUNDS AND METHODS FOR PREPARATION OF CONJUGATE REAGENTS
#182METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#183METHODS AND KITS FOR DETERMINING PROTEIN-BOUND BIOMARKERS
#184BIOMARKERS
#185Method and apparatus for detection of a biomarker by alternating current electrokinetics
#186SGII AS A PROGNOSTIC MARKER IN CONDITIONS WHICH REQUIRE CRITICAL CARE
#187ASSAYS AND METHODS PERTAINING TO PRE-AMYLOID INTERMEDIATES
#188METHODS OF DIAGNOSING ENDOMETRIOSIS
#189Diagnostic and Prognostic Markers for Cancer
#190SYSTEMS AND METHODS FOR SAMPLE USE MAXIMIZATION
#191Quantitative diagnostic methods using multiple parameters
#192Multiplexed assay methods
#193Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
#194Detection of bacterial infections in subjects suffering from dyspnea
#195Modulation of activity of neurotrophins
#196Hepcidin binding nucleic acids
#197COMBINED NATRIURETIC PEPTIDE ASSAYS
#198METHODS AND ASSAYS FOR CLASSIFYING FOODSTUFF AND/OR BEVERAGE AND/OR DIET AND/OR NUTRITION REGIMEN AND/OR MEDICAMENT IN VIEW OF AN EFFECT ON THE CARDIOVASCULAR SYSTEM
#199Method of generating a dosing schedule using gamma secretase notch biomarkers
#200Methods and apparatus for screening for chromosomal abnormalities
#201Methods and Kits for Predicting the Onset of Labour
#202Nucleic acid ligand complexes
#203Endometriosis markers
#204Methods of diagnosing endometriosis
#205Method for Sensing a Chemical
#206Methods for inhibiting the development of huntington's disease
#207Direct enzyme immunoassay for measurement of serum progesterone levels
#208Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels
#209DIAGNOSTIC METHOD FOR DISORDERS USING COPEPTIN
#210Identification of cancer protein biomarkers using proteomic techniques
#211Cancer therapeutic agents comprising a ligand for the neuromedin u receptor 2 (fm4) molecule as an active ingredient
#212Apparatus And Methods For The Detection Of Plasma Metanephrines
#213Multiplexed assay methods
#214PROGNOSIS AND RISK ASSESSMENT IN PATIENTS SUFFERING FROM HEART FAILURE BY DETERMINING THE LEVEL OF ADM AND BNP
#215METHODS OF DIAGNOSING CARDIOVASCULAR DISEASE
#216ADIPONECTIN FOR THE TREATMENT AND DIAGNOSIS OF ALBUMINURIA
#217Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance
#218Gamma secretase notch biomarkers
#219Antibody to inhibin/ activin β-B subunit
#220Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides
#221ISOLATED HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES AND METHODS AND KITS FOR DETECTING HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES
#222Determination of serum anti-mullerian hormone as a diagnostic test for spay in companion animals
#223Diagnostic method for disorders using copeptin
#224Pancreatic polypeptide as target/marker of beta cell failure
#225Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
#226Methods of diagnosing endometriosis
#227Inhibition of Bradykinin Release
#228PERMITTIVITY-BASED MATERIAL SENSOR
#229In vitro method for the diagnosis of neurodegenerative diseases
#230Obesity Markers And Uses Thereof
#231Leptin antagonist and method for quantitative measurement of leptin
#232Gamma secretase notch biomarkers
#233Modulation of activity of neurotrophins
#234Methods and apparatus for screening for chromosomal abmormalities
#235Methods for prediction and prognosis of cancer, and monitoring cancer therapy
#236Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance
#237Antibody against NPW
#238Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#239Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
#240Inhibition of bradykinin release
#241Multiplexed assay methods
#242Tenascin-C nucleic acid ligands
#243Methods of diagnosing cardiovascular disease
#244Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
#245Inhibin-A: a marker for differentiation, diagnosing and screening abnormal pregnancies
#246Methods and compositions for modulating and detecting activin dimer and dimer formation
#247Identification of cancer protein biomarkers using proteomic techniques
#248Methods for determining the amount of peptide YY in blood
#249Nucleic acid ligand complexes
#250Truncation SELEX method
#251High affinity RNA ligands of basic fibroblast growth factor
#252Method and composition for inducing weight loss
#253Method for measurement of bioavailable testosterone